Use of Simplified HCV Treatment Guidelines and Minimal Monitoring Recommendations Among PEH

Target Audience

The educational design of this activity addresses the needs of primary care, infectious disease, public health, and preventive medicine physicians, physician assistants, nurse practitioners, registered nurses, pharmacists, and social workers involved in the treatment of patients with HIV and hepatitis C virus (HCV), specifically those experiencing homelessness.

Educational Objectives

Upon completion of this activity, participants should be better able to:

• Describe AASLD/IDSA simplified HCV treatment and monitoring guidelines
• Review reinfection prevention tactics that address the needs and circumstances of people experiencing homelessness (PEH)
• Identify community-based opportunities and logistics for colocation of HCV healthcare services with SUD and housing programs

Program Description

HCV is prevalent among PEH, particularly among people who inject drugs (PWID). Fortunately, HCV is easy to treat with multiple treatment options recommended by the simplified HCV guidelines. Clinicians, however, lack familiarity with these guidelines, eligible populations, and monitoring requirements for PEH with HCV. In this 1-hour webinar, Dr. Stacey Trooskin and Dr. Arsalan Shah will discuss simplified guidelines and eligible populations (including PWID and PEH), as well as monitoring requirements and strategies to optimize adherence among this population. Clinic models of colocalized HCV and substance use disorder treatment services will be discussed.

Program Agenda

3:00 pm       Welcome & Introduction
3:05 pm       Reviewing simplified HCV guidelines
3:20 pm       Modifying minimal-monitoring guidelines to optimize adherence support, treatment completion, and sustained virologic response
3:35 pm       Effective models of HCV treatment colocation with SUD centers
3:50 pm       Question & Answer Session

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications.  Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hour is provided by Global. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement

Global is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Credit Designation

Global designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-22-102-L02-P)

This is a knowledge-based activity.

National Association of Social Workers

This program is approved by the National Association of Social Workers (Approval # 886551415-3235) for 1.0 continuing education contact hour.

Disclosures of Relevant Financial Relationships

Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global.  All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias. 

All relevant financial relationships have been mitigated.

Arsalan "RC" Shah, PharmD, MBA: Nothing to disclose

Stacey B. Trooskin, MD, PhD, MPH: Consulting Fees: Theratechnologies Inc.; Contracted Research: Gilead Sciences, Inc.

The following planners and managers have no relevant financial relationships with ineligible companies:

Rhys Williams, MSN, FNP-C, RN, Lindsay Borvansky, Andrea Funk, Liddy Knight, Ashley Cann, Lauren Sinclair, Chad Gurdgiel, LSW, Gena Dolson, MS, Elizabeth Manheim, PhD, Jim Kappler, PhD

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global and Integritas Communications do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must attend the live webinar, complete the posttest with 70% or higher, and complete the program evaluation. Pharmacist learners must check CPE monitor within 30 days for their credit.

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Fee Information & Refund/Cancellation Policy

There is no fee for this educational activity.

Americans With Disabilities

Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact Integritas Communications at info@exchangecme.com to discuss their specific needs.

Integritas Contact Information

For information about this program, please contact us at info@exchangecme.com.

We would like to thank HealthHIV and HealthHCV for their contributions and support.

This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by independent educational grants from AbbVie Inc., Gilead Sciences, Inc., and ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.